Amanda Termuhlen works in the field of Pediatric Hematology & Oncology. He researched medicine at The Ohio State University College of Medicine. Amanda Termuhlen is a published physician as well. He has 38 publications published. The latest was: CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells.
![]() |
Dr. Caitlin J. Agrawal, MD
![]() |
![]() |
Dr. Keri A. Streby, MD
![]() |
![]() |
Dr. Nicholas D. Yeager, MD
![]() |
![]() |
Dr. Sarah O'Brien, MD
![]() |
![]() |
Dr. Anthony N. Audino, MD
![]() |
![]() |
Dr. Susan I. Vear, MD
![]() |
![]() |
Dr. Randal S. Olshefski, MD
![]() |
![]() |
Hemalatha G. Rangarajan, MB
![]() |